Adverse effect of digestants, subsequent encounter

This code signifies a patient experiencing an unintended and undesirable reaction to a digestant medication during a follow-up visit. This adverse effect is not due to poisoning or overdose, but rather a normal therapeutic dose of the substance. The patient is being seen for ongoing management or evaluation of this previously identified adverse reaction.

Apply this code when a patient presents for continued care related to an adverse effect from a digestant, such as an enzyme supplement (e.g., pancrelipase) or a bile acid preparation. This would include scenarios where the patient is being monitored for resolution of symptoms, adjusting treatment, or managing chronic side effects from the digestant. It is used after the initial encounter for the adverse effect.

• Always use in conjunction with a code identifying the specific adverse effect (e.g., nausea, abdominal pain).
• Ensure the encounter is a "subsequent encounter" and not the initial treatment for the adverse effect.
• Verify the medication in question is classified as a "digestant" to ensure accurate coding.